SPPAM
BIIB icon

Summit Partners Public Asset Management’s Biogen BIIB Stock Holding History

Summit Partners Public Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-20,830
Closed -$5.39M – 130
2023
Q4 		$5.39M Buy
+20,830
New +$5.12M 0.22% 105

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Summit Partners Public Asset Management's BIIB Position: Q1 2024 in Review

Summit Partners Public Asset Management sold out of Biogen (BIIB) in Q1 2024, closing a stake of 20,830 shares — an estimated $5.39M sold.

Summit Partners Public Asset Management first reported a position in BIIB in Q4 2023 and held it in 1 quarter. The position peaked at $5.39M in Q4 2023. 954 funds tracked by Wall St. Rank hold BIIB as of Q1 2024.

  • Summit Partners Public Asset Management reported no remaining Biogen position as of Q1 2024 after selling out during the quarter.
  • Summit Partners Public Asset Management sold 20,830 Biogen shares in Q1 2024, an estimated $5.39M.
  • Summit Partners Public Asset Management first reported a position in Biogen in Q4 2023 and held it in 1 quarter.
  • Summit Partners Public Asset Management's Biogen position peaked at $5.39M in Q4 2023.
  • 954 funds tracked by Wall St. Rank held Biogen as of Q1 2024.

Based on Summit Partners Public Asset Management's 13F filing for Q1 2024, filed 15 May 2024.